1. Niemann I, Vejerslev L, Froding L, et al. Gestational Trophoblastic Diseases, Clinical guidelines for diagnosis, treatment, follow-up, and counseling. Danish Med J. 2015; 62(11): 1-19.
2. Alhamdan D, Bignardi T, Condous G. Recognising gestational trophoblastic disease. Best Pract Res Clin Obstet Gynaecol. 2009; 23(4): 565-73. [
DOI:10.1016/j.bpobgyn.2009.03.001]
3. LeGallo RD, Stelow EB, Ramirez NC, Atkins KA. Diagnosis of hydatidiform moles using p57 immunohistochemistry and HER2 fluorescent in situ hybridization. Am J Clin Pathol. 2008; 129(5): 749-55. [
DOI:10.1309/7XRL378C22W7APBT]
4. Berkowitz RS, Goldstein DP. Current advances in the management of gestational trophoblastic disease. Gynecol Oncol. 2013; 128(1): 3–5. [
DOI:10.1016/j.ygyno.2012.07.116]
5. Ngan HYS, Kohorn EI, Cole LA, Kurman RJ, , Kim SJ, Lurain JR, et al. Trophoblastic disease. International Journal of Gynecology and Obstetrics. 2012; 119: 130-136. [
DOI:10.1016/S0020-7292(12)60026-5]
6. Hegab HM, Schindler AE. The prognostic value of serum inhibin, 17 beta- estradiol and progestrone in cases of hydatidiform mole. Gynecol Endocrinol. 2004; 18(2): 107-13. [
DOI:10.1080/09513590310001652991]
7. Kubelka-Sabit KB, Prodanova I, Jasar D, et al. Molecular and Immunohistochemical Characteristics of Complete Hydatidiform Moles. Balkan J Med Genet. 2017; 20(1): 27-34. [
DOI:10.1515/bjmg-2017-0009]
8. Atabaki Pasdar F, Khooei A, Fazel A, Mahmoudi M, Nikravesh MR, Khaje Delui M. Diagnostic value of lectins in differentiation of molar placentas. Iran J Basic Med Sci. 2012; 15(6): 1140-7.
9. Samadder A, Kar R. Utility of p57 immunohistochemistry in differentiating between complete mole, partial mole & non-molar or hydropic abortus. Indian J Med Res. 2017; 145(1): 133–137. [
DOI:10.4103/ijmr.IJMR_982_15]
10. Rambaruth ND1, Greenwell P, Dwek MV. The lectin Helix pomatia agglutinin recognizes O-GlcNAc containing glycoproteins in human breast cancer. Glycobiology. 2012; 22(6): 839-48. [
DOI:10.1093/glycob/cws051]
11. Brooks SA, Leathem AJ, Camplejohn RS, Gregory W. Markers of prognosis in breast cancer--the relationship between binding of the lectin HPA and histological grade, SPF, and ploidy. Breast Cancer Res Treat. 1993; 25(3): 247-56. [
DOI:10.1007/BF00689839]
12. Welinder C, Jansson B, Ferno M, Olson H, Baldetorp B. Expression of Helix Pomatia Lectin Binding Glycoproteins in women with breast cancer in relationship to their blood group. J Proteome Res. 2009; 8(2): 782-7. [
DOI:10.1021/pr800444b]
13. Brooks SA. The involvement of Helix pomatia lectin (HPA) binding N-acetylgalactosamine glycans in cancer progression. Histol Histopathol 2000; 15(1): 143–158.
14. Kakeji Y, Tsujitani S, Mori M, Maehara Y, Sugimachi K. Helix pomatia agglutinin binding activity is a predictor of survival time for patients with gastric carcinoma. Cancer 1991; 68: 2438–2442.
https://doi.org/10.1002/1097-0142(19911201)68:11<2438::AID-CNCR2820681119>3.0.CO;2-# [
DOI:10.1002/1097-0142(19911201)68:113.0.CO;2-#]
15. Arab MR, Salari S, Karimi M, Mofidpour H. Lectin histochemical study of cell surface glycoconjugate in gastric carcinoma using helix pomatia agglutinin. Acta Med Iran. 2010; 48(4): 209-13.
16. Saint-Guirons J, Zeqiraj E, Schumacher U, Greenwell P, Dwek M. Proteome analysis of metastatic colorectal cancer cells recognized by the lectin Helix pomatia agglutinin (HPA). Proteomics. 2007; 7(22): 4082-4089. [
DOI:10.1002/pmic.200700434]
17. Schumacher U, Higgs D, Loizidou M, Pickering R, Leathem A, Taylor I. Helix pomatia agglutinin binding is a useful prognostic indicator in colorectal carcinoma. Cancer. 1994; 74: 3104–3107.
https://doi.org/10.1002/1097-0142(19941215)74:12<3104::AID-CNCR2820741207>3.0.CO;2-0 [
DOI:10.1002/1097-0142(19941215)74:123.0.CO;2-0]
18. Shiraishi T, Atsumi S, Yatani R. Comparative study of prostatic carcinoma bone metastasis among Japanese in Japan and Japanese Americans and whites in Hawaii. Adv Exp Med Biol. 1992; 324: 7–16. [
DOI:10.1007/978-1-4615-3398-6_2]
19. Thower S, Bulmer JN. Further studies of lectin binding by villous and extravillous trophoblast in normal and pathological pregnancy. Int J Gynecol Pathol. 1991; 10(3): 238-251. [
DOI:10.1097/00004347-199107000-00003]
20. Arab M, Sepehri Z, Eimani H, Karimi M, Sargolzaie F. Histochemical Study of N-acetylgalactosamine Containing Glycoconjugate in Intraductal Carcinoma of the Breast by HPA Lectin. Yakhteh Med J. 2006; 7(4): 216-221.
21. Korourian S, Siegel E, Kieber-Emmons T, Monzavi-Karbassi B. Expression analysis of carbohydrate antigens in ductal carcinoma in situ of the breast by lectin histochemistry. BMC Cancer. 2008; 14; 8:136.
22. Ngan HYS, Seckl MJ, Berkowitz RS, Xiang Y, Golfier F, Sekharan PK, et al. Trophoblastic disease. International Journal of Gynecology and Obstetrics. 2015; 131: 123-126. [
DOI:10.1016/j.ijgo.2015.06.008]
23. Horn LC, Kowalzik J, Bilek K, Richter CE, Einekel J. Prognostic value of trophoblastic proliferation in complete hydatidiform moles in predicting persistent diseases. Pathol Res & Pract. 2006 (202): 151 156. [
DOI:10.1016/j.prp.2005.11.009]
24. Bae SN, Kim SJ. Telomerase activity in complete hydatidiform mole. Am J Obstet Gynecol. 1998; 180(2): 328-333. [
DOI:10.1016/S0002-9378(99)70208-5]
25. Shih IM, Kurman RJ. The pathology of intermediate trophoblastic tumors and tumor-like lesions. Int J Gynecol Pathol. 2001; 20(1): 31–47. [
DOI:10.1097/00004347-200101000-00004]
26. Jones CJ, Dantzer V, Leiser R, Krebs C, Stoddart RW. Localisation of glycans in the placenta: a comparative study of epitheliochorial, endotheliochorial, and haemomonochorial placentation. Microsc Res Tech. 1997; 38(1-2): 100–14.
https://doi.org/10.1002/(SICI)1097-0029(19970701/15)38:1/2<100::AID-JEMT11>3.0.CO;2-T [
DOI:10.1002/(SICI)1097-0029(19970701/15)38:1/23.0.CO;2-T]
27. Whyte A. Lectin binding by microvillous membranes and coated-pit regions of human syncytial trophoblast. Histochem J. 1980; 12(5): 599–607. [
DOI:10.1007/BF01011933]
28. Lee MC, Damjanov I. Lectin histochemistry of human placenta. Differentiation. 1984; 28(2): 123–8. [
DOI:10.1111/j.1432-0436.1984.tb00275.x]
29. Brooks SA, Lymborus M,Schumacher U, Leathem AJ . Histochemistry to detect Helix Pomatia lectin in Breast Cancer: methodology makes a differences. J Histochem Cytochem. 1996; 44: 519-24. [
DOI:10.1177/44.5.8627008]
30. Gusterson BA. Prognostic Value of Helix Pomatia in Breast Cancer. Br J Cancer 1993;68:146-50. [
DOI:10.1038/bjc.1993.303]
31. Taylor CW, Anbazhagan R, Jayatilake H, et al. Helix Pomatia in Breast Cancer. Lancet. 1991; 338: 580-584. [
DOI:10.1016/0140-6736(91)91154-M]
32. Schumacher DU, Randall CJ, Ramsay AD, Schumacher U. Is the binding of the lectin Helix pomatia agglutinin (HPA) of prognostic relevance in tumours of the upper aerodigestive tract? Eur J Surg Oncol. 1996; 22(6): 618-20. [
DOI:10.1016/S0748-7983(96)92424-5]
33. Yoshida Y, Okamura T, Yano K, Taga S, Ezaki T. Histopathological characteristics associated with long-term survival in stage III esophageal carcinoma. Cancer. 1994; 7: 147-9.
34. Gauster M1, Blaschitz A, Siwetz M, Huppertz B. Keratins in the human trophoblast. Histol Histopathol. 2013; 28(7): 817-25.